Amedeo Smart

Free Medical Literature Service

 

Amedeo

Pancreatitis
  Free Subscription

Articles published in
Br J Surg
    April 2024
  1. UNDERWOOD PW, Cloyd JM
    Comment on: Predictive value of baseline serum carbohydrate antigen 19-9 level on treatment effect of neoadjuvant chemoradiotherapy in patients with resectable and borderline resectable pancreatic cancer in two randomized trials.
    Br J Surg. 2024;111:znae085.
    >> Share

    March 2024
  2. THEIJSE RT, Stoop TF, Janssen QP, Prakash LR, et al
    Impact of a non-therapeutic laparotomy in patients with locally advanced pancreatic cancer treated with induction (m)FOLFIRINOX: Trans-Atlantic Pancreatic Surgery (TAPS) Consortium study.
    Br J Surg. 2024;111:znae033.
    >> Share

  3. IMAMURA T, Ashida R, Urakami K, Ohshima K, et al
    Comprehensive sequencing of circulating tumour DNA in resectable pancreatic cancer.
    Br J Surg. 2024;111:znae059.
    >> Share

    January 2024
  4. VAN BEEK DJ, Van Den Heede K, Rinkes IB, Norlen O, et al
    Surgery for advanced pancreatic neuroendocrine neoplasms: recommendations based on a consensus meeting of the European Society of Endocrine Surgeons (ESES).
    Br J Surg. 2024;111:znae017.
    >> Share

  5. LARSSON P, Soreide K
    Surgery for oligometastatic pancreatic cancer: next frontier?
    Br J Surg. 2024;111:znad419.
    >> Share

  6. OMIYA K, Maekawa A, Oba A, Inoue Y, et al
    A proposal of ABCD metastasectomy criteria for synchronous/metachronous metastatic pancreatic cancer in the era of multidisciplinary treatment.
    Br J Surg. 2024;111:znad417.
    >> Share

    December 2023
  7. ONNEKINK AM, Michiels N, Klatte DCF, Oldenburg L, et al
    Surgical outcomes after pancreatic surgery in patients with a germline CDKN2A/p16 pathogenic variant under surveillance.
    Br J Surg. 2023 Dec 29:znad430. doi: 10.1093.
    >> Share

  8. HALL LA, Powell-Brett S, Halle-Smith J, Ward L, et al
    Pancreatic exocrine insufficiency after non-pancreatic upper gastrointestinal surgery: meta-analysis.
    Br J Surg. 2023 Dec 8:znad369. doi: 10.1093.
    >> Share

    November 2023
  9. KIRKEGARD J, Ladekarl M, Johannsen IR, Mortensen F, et al
    Effect of adjuvant chemotherapy after pancreatectomy in patients with node-negative pancreatic cancer: target trial emulation.
    Br J Surg. 2023 Nov 25:znad398. doi: 10.1093.
    >> Share

  10. SCHLAPFER M, Schadde E, Braun J, Soll C, et al
    Effect of volatile versus total intravenous anaesthesia on circulating tumour cells after pancreatic adenocarcinoma resection: multicentre randomized clinical trial.
    Br J Surg. 2023 Nov 14:znad357. doi: 10.1093.
    >> Share

    October 2023
  11. BOAG KF, Britton E, Knight SR, Coe PO, et al
    Definition and management of intra-abdominal metachronous oligometastatic pancreatic cancer: a systematic review.
    Br J Surg. 2023 Oct 31:znad338. doi: 10.1093.
    >> Share

  12. UMANS DS, Timmerhuis HC, Anten MGF, Bhalla A, et al
    Prospective multicentre study of indications for surgery in patients with idiopathic acute pancreatitis following endoscopic ultrasonography (PICUS).
    Br J Surg. 2023 Oct 9:znad318. doi: 10.1093.
    >> Share

    July 2023
  13. DOPPENBERG D, van Dam JL, Han Y, Bonsing BA, et al
    Predictive value of baseline serum carbohydrate antigen 19-9 level on treatment effect of neoadjuvant chemoradiotherapy in patients with resectable and borderline resectable pancreatic cancer in two randomized trials.
    Br J Surg. 2023 Jul 13:znad210. doi: 10.1093.
    >> Share

    June 2023
  14. STRAND K, Moller JH
    Fluid treatment in acute pancreatitis: a careful balancing act.
    Br J Surg. 2023 Jun 16:znad155. doi: 10.1093.
    >> Share

  15. MAGGINO L, Malleo G, Crippa S, Belfiori G, et al
    Pathological staging in postneoadjuvant pancreatectomy for pancreatic cancer: implications for adjuvant therapy.
    Br J Surg. 2023 Jun 1:znad146. doi: 10.1093.
    >> Share

  16. AMMER-HERRMENAU C, Lingens CHM, Ratei CS, Heuer C, et al
    Whole 16S rRNA sequencing of the oral microbiome predicts postoperative pancreatic fistula: prospective observational cohort study.
    Br J Surg. 2023 Jun 1:znad129. doi: 10.1093.
    >> Share

    February 2023
  17. HUTTNER FJ, Mauch M, Heckler M, Hackert T, et al
    Influence of beta-blockers and other non-cancer drugs on outcomes after pancreatic cancer resection.
    Br J Surg. 2023 Feb 2:znac434. doi: 10.1093.
    >> Share

    January 2023
  18. SHI X, Yin X, Gao S, Li B, et al
    Morphomolecular staging to improve stratification of patients with node-negative pancreatic cancer.
    Br J Surg. 2023 Jan 12:znac457. doi: 10.1093.
    >> Share

  19. ZAHARIA C, Soreide K
    Call for better response evaluation after neoadjuvant therapy in pancreatic cancer.
    Br J Surg. 2023 Jan 12:znac452. doi: 10.1093.
    >> Share

    December 2022

  20. Erratum to: Impact of classical and basal-like molecular subtypes on overall survival in resected pancreatic cancer in the SPACIOUS-2 multicentre study.
    Br J Surg. 2022 Dec 3:znac429. doi: 10.1093.
    >> Share

  21. GOEL N, Rhim AD, Xi H, Olive KP, et al
    Transfusion of salvaged red blood cells during pancreatic ductal adenocarcinoma operations.
    Br J Surg. 2022 Dec 3:znac393. doi: 10.1093.
    >> Share

    November 2022
  22. ISHII K, Yokoyama Y, Yonekawa Y, Hayashi D, et al
    Tranexamic acid and blood loss in pancreaticoduodenectomy: TAC-PD randomized clinical trial.
    Br J Surg. 2022 Nov 16. pii: 6828840. doi: 10.1093.
    >> Share

  23. YANG G, Qiu J, Xu J, Xiong G, et al
    Using a microRNA panel of circulating exosomes for diagnosis of pancreatic cancer: multicentre case-control study.
    Br J Surg. 2022 Nov 11. pii: 6821339. doi: 10.1093.
    >> Share

  24. GIMBERG K, Enochsson L, Sandblom G
    Mortality and recurrence risk after a first episode of acute pancreatitis in the elderly: population-based study.
    Br J Surg. 2022 Nov 10. pii: 6819853. doi: 10.1093.
    >> Share

  25. BROWN ZJ, Heh V, Labiner HE, Brock GN, et al
    Surgical resection rates after neoadjuvant therapy for localized pancreatic ductal adenocarcinoma: meta-analysis.
    Br J Surg. 2022 Nov 8. pii: 6811500. doi: 10.1093.
    >> Share

  26. JANSSEN BV, van Roessel S, van Dieren S, de Boer O, et al
    Histopathological tumour response scoring in resected pancreatic cancer following neoadjuvant therapy: international interobserver study (ISGPP-1).
    Br J Surg. 2022 Nov 4. pii: 6798894. doi: 10.1093.
    >> Share

  27. YUAN Y, Chen Y
    Comment on: Survival after active surveillance versus upfront surgery for incidental small pancreatic neuroendocrine tumours.
    Br J Surg. 2022 Nov 2. pii: 6794078. doi: 10.1093.
    >> Share

    October 2022
  28. PECORELLI N, Palumbo D, Guarneri G, Gritti C, et al
    Preoperative CT image analysis to improve risk stratification for clinically relevant pancreatic fistula after distal pancreatectomy.
    Br J Surg. 2022 Oct 29. pii: 6779864. doi: 10.1093.
    >> Share

  29. RICCI C, Partelli S, Landoni L, Bassi C, et al
    Author response to: Survival after active surveillance versus upfront surgery for incidental small pancreatic neuroendocrine tumours.
    Br J Surg. 2022 Oct 26. pii: 6774456. doi: 10.1093.
    >> Share

  30. OBA A, Wu YHA, Schulick R, Del Chiaro M, et al
    Author response to: Comment on: Comparing neoadjuvant chemotherapy with or without radiation therapy for pancreatic ductal adenocarcinoma: National Cancer Database cohort analysis.
    Br J Surg. 2022 Oct 17. pii: 6761813. doi: 10.1093.
    >> Share

  31. CHEN G, Chen Y
    Comment on: Comparing neoadjuvant chemotherapy with or without radiation therapy for pancreatic ductal adenocarcinoma: National Cancer Database cohort analysis.
    Br J Surg. 2022 Oct 3. pii: 6747090. doi: 10.1093.
    >> Share

    August 2022
  32. PARTELLI S, Massironi S, Zerbi A, Niccoli P, et al
    Management of asymptomatic sporadic non-functioning pancreatic neuroendocrine neoplasms no larger than 2 cm: interim analysis of prospective ASPEN trial.
    Br J Surg. 2022 Aug 20. pii: 6672718. doi: 10.1093.
    >> Share

  33. BONSDORFF A, Ghorbani P, Helantera I, Tarvainen T, et al
    Development and external validation of DISPAIR fistula risk score for clinically relevant postoperative pancreatic fistula risk after distal pancreatectomy.
    Br J Surg. 2022 Aug 19. pii: 6671587. doi: 10.1093.
    >> Share

  34. SUURMEIJER JA, Soer EC, Dings MPG, Kim Y, et al
    Impact of classical and basal-like molecular subtypes on overall survival in resected pancreatic cancer in the SPACIOUS-2 multicentre study.
    Br J Surg. 2022 Aug 18. pii: 6670906. doi: 10.1093.
    >> Share

  35. LIU X, Zhu M
    Comment on: Acute pancreatitis in pregnancy: meta-analysis of maternal and fetal outcomes.
    Br J Surg. 2022 Aug 18. pii: 6670911. doi: 10.1093.
    >> Share

    July 2022
  36. VAN WIJK L, Bongers BC, Berkel AEM, Buis CI, et al
    Improved preoperative aerobic fitness following a home-based bimodal prehabilitation programme in high-risk patients scheduled for liver or pancreatic resection.
    Br J Surg. 2022 Jul 19. pii: 6646051. doi: 10.1093.
    >> Share

  37. PERY R, Smoot RL, Thiels CA, Cleary SP, et al
    Hepatobiliary and pancreatic resection for cholangiocarcinoma in patients with primary sclerosing cholangitis.
    Br J Surg. 2022 Jul 15. pii: 6644759. doi: 10.1093.
    >> Share

    June 2022
  38. HALLE-SMITH JM, Pande R, Hall L, Hodson J, et al
    Perioperative interventions to reduce pancreatic fistula following pancreatoduodenectomy: meta-analysis.
    Br J Surg. 2022 Jun 21. pii: 6612720. doi: 10.1093.
    >> Share

    May 2022
  39. KEMPENEERS MA, Boermeester MA
    Author response to: Short- and long-term outcomes of selective use of Frey or extended lateral pancreaticojejunostomy in chronic pancreatitis.
    Br J Surg. 2022 May 20. pii: 6589957. doi: 10.1093.
    >> Share

  40. RICCI C, Partelli S, Landoni L, Rinzivillo M, et al
    Survival after active surveillance versus upfront surgery for incidental small pancreatic neuroendocrine tumours.
    Br J Surg. 2022 May 20. pii: 6589936. doi: 10.1093.
    >> Share

  41. JULIANOV A, Saroglu A
    Comment on: Short- and long-term outcomes of selective use of Frey or extended lateral pancreaticojejunostomy in chronic pancreatitis.
    Br J Surg. 2022 May 20. pii: 6589664. doi: 10.1093.
    >> Share

  42. HEIDSMA CM, Nieveen van Dijkum EJ
    Author response to: Watchful waiting for small non-functional pancreatic neuroendocrine tumours: Nationwide prospective cohort study (PANDORA).
    Br J Surg. 2022 May 17. pii: 6587120. doi: 10.1093.
    >> Share

  43. WANG X
    Comment on: Watchful waiting for small non-functional pancreatic neuroendocrine tumours: nationwide prospective cohort study (PANDORA).
    Br J Surg. 2022 May 17. pii: 6587118. doi: 10.1093.
    >> Share

  44. NICKEL F, Lang F, Kowalewski KF, Haney CM, et al
    Pancreatic surgery with or without drainage: propensity score-matched study.
    Br J Surg. 2022 May 17. pii: 6586613. doi: 10.1093.
    >> Share

  45. DAMANAKIS AI, Toader J, Wahler I, Plum P, et al
    Influence of patient sex on outcomes after pancreatic surgery: multicentre study.
    Br J Surg. 2022 May 16. pii: 6586217. doi: 10.1093.
    >> Share

    April 2022
  46. WANG X, Wang Z, Ke N
    Comment on: Venous wedge and segment resection during pancreatoduodenectomy for pancreatic cancer: impact on short- and long-term outcomes in a nationwide cohort analysis.
    Br J Surg. 2022 Apr 13. pii: 6567930. doi: 10.1093.
    >> Share

  47. GROEN JV, Michiels N, Mieog JSD
    Author response to: Venous wedge and segment resection during pancreatoduodenectomy for pancreatic cancer: impact on short- and long-term outcomes in a nationwide cohort analysis.
    Br J Surg. 2022 Apr 13. pii: 6567931. doi: 10.1093.
    >> Share

    March 2022
  48. TAN Q, Ke N
    Comment on: Radiological tumour invasion of splenic artery or vein in patients with pancreatic body or tail adenocarcinoma and effect on recurrence and survival.
    Br J Surg. 2022 Mar 2. pii: 6540575. doi: 10.1093.
    >> Share

    February 2022
  49. OBA A, Wu YHA, Colborn KL, Karam SD, et al
    Comparing neoadjuvant chemotherapy with or without radiation therapy for pancreatic ductal adenocarcinoma: National Cancer Database cohort analysis.
    Br J Surg. 2022 Feb 8. pii: 6524037. doi: 10.1093.
    >> Share

  50. KEMPENEERS MA, van Hemert AKE, van der Hoek M, Issa Y, et al
    Short- and long-term outcomes of selective use of Frey or extended lateral pancreaticojejunostomy in chronic pancreatitis.
    Br J Surg. 2022 Feb 4. pii: 6522949. doi: 10.1093.
    >> Share

    January 2022
  51. VUILLE-DIT-BILLE RN, Staerkle RF, Soll C, Troller R, et al
    Extended versus standard lymph node dissection for pancreatic head and periampullary adenocarcinoma: systematic review.
    Br J Surg. 2022 Jan 18. pii: 6511022. doi: 10.1093.
    >> Share

    November 2021
  52. GROEN JV, Michiels N, van Roessel S, Besselink MG, et al
    Venous wedge and segment resection during pancreatoduodenectomy for pancreatic cancer: impact on short- and long-term outcomes in a nationwide cohort analysis.
    Br J Surg. 2021 Nov 17. pii: 6430361. doi: 10.1093.
    >> Share

  53. HUGHES DL
    Author response to: Acute pancreatitis in pregnancy: meta-analysis of maternal and foetal outcomes.
    Br J Surg. 2021 Nov 3. pii: 6420339. doi: 10.1093.
    >> Share

  54. YANG DJ, Li M, Lu HM
    Comment on: Acute pancreatitis in pregnancy: meta-analysis of maternal and foetal outcomes.
    Br J Surg. 2021 Nov 3. pii: 6420337. doi: 10.1093.
    >> Share

    October 2021
  55. KANG JS, Choi YJ, Byun Y, Han Y, et al
    Radiological tumour invasion of splenic artery or vein in patients with pancreatic body or tail adenocarcinoma and effect on recurrence and survival.
    Br J Surg. 2021 Oct 27. pii: 6412735. doi: 10.1093.
    >> Share

  56. ISSA Y, Boermeester MA
    Management of chronic pancreatitis: more pain than gain?
    Br J Surg. 2021 Oct 14. pii: 6396997. doi: 10.1093.
    >> Share

  57. GROEN JV, Smits FJ, Koole D, Besselink MG, et al
    Completion pancreatectomy or a pancreas-preserving procedure during relaparotomy for pancreatic fistula after pancreatoduodenectomy: a multicentre cohort study and meta-analysis.
    Br J Surg. 2021 Oct 5. pii: 6381514. doi: 10.1093.
    >> Share

    September 2021
  58. BHOME R, Karavias D, Armstrong T, Hamady Z, et al
    Intraoperative radiotherapy for pancreatic cancer: implementation and initial experience.
    Br J Surg. 2021 Sep 29. pii: 6377876. doi: 10.1093.
    >> Share

  59. PEDRAZZOLI S
    Comment on: Prevention, prediction, and mitigation of postoperative pancreatic fistula.
    Br J Surg. 2021 Sep 28. pii: 6377196. doi: 10.1093.
    >> Share

  60. TSILIMIGRAS DI, Pawlik TM
    Pancreatic neuroendocrine tumours: conservative versus surgical management.
    Br J Surg. 2021 Sep 14. pii: 6370089. doi: 10.1093.
    >> Share

    August 2021
  61. LEE W, Oh M, Kim JS, Park Y, et al
    Metabolic activity by FDG-PET/CT after neoadjuvant chemotherapy in borderline resectable and locally advanced pancreatic cancer and association with survival.
    Br J Surg. 2021 Aug 11. pii: 6347629. doi: 10.1093.
    >> Share

    July 2021
  62. PANDANABOYANA S
    Exploring Koch's postulate for SARS-CoV-2-induced acute pancreatitis: is it all about the ACE?
    Br J Surg. 2021 Jul 6. pii: 6316026. doi: 10.1093.
    >> Share

    June 2021
  63. HUGHES DL, Hughes A, White PB, Silva MA, et al
    Acute pancreatitis in pregnancy: meta-analysis of maternal and fetal outcomes.
    Br J Surg. 2021 Jun 28. pii: 6310415. doi: 10.1093.
    >> Share

  64. WENIGER M, Hank T, Qadan M, Ciprani D, et al
    Influence of Klebsiella pneumoniae and quinolone treatment on prognosis in patients with pancreatic cancer.
    Br J Surg. 2021;108:709-716.
    >> Share

  65. OBA A, Wu YHA, Lieu CH, Meguid C, et al
    Outcome of neoadjuvant treatment for pancreatic cancer in elderly patients: comparative, observational cohort study.
    Br J Surg. 2021 Jun 22. pii: 6307483. doi: 10.1093.
    >> Share

    May 2021
  66. SCHNEIDER M, Hackert T, Strobel O, Buchler MW, et al
    Technical advances in surgery for pancreatic cancer.
    Br J Surg. 2021 May 27. pii: 6287225. doi: 10.1093.
    >> Share

  67. LAYTON GR, Chung WY, Isherwood J, Fraser RE, et al
    Endoscopic retrograde cholangiopancreatography in the COVID era: considerations for hepatobiliary and pancreatic surgery units.
    Br J Surg. 2021 May 17. pii: 6277144. doi: 10.1093.
    >> Share

  68. MARCHEGIANI G, Bassi C
    Prevention, prediction, and mitigation of postoperative pancreatic fistula.
    Br J Surg. 2021 May 4. pii: 6263467. doi: 10.1093.
    >> Share

    April 2021
  69. KOSTI A, Rybinski B, Javanmard-Emamghissi H, Laing R, et al
    Protocol letter: multicentre prospective cohort study of the early management of acute pancreatitis in Great Britain and Ireland: PANC Study (Pancreatitis: A National Cohort Study).
    Br J Surg. 2021 Apr 12. pii: 6224208. doi: 10.1093.
    >> Share

    March 2021
  70. HEIDSMA CM, Engelsman AF, van Dieren S, Stommel MWJ, et al
    Watchful waiting for small non-functional pancreatic neuroendocrine tumours: nationwide prospective cohort study (PANDORA).
    Br J Surg. 2021 Mar 30. pii: 6202974. doi: 10.1093.
    >> Share

  71. LATENSTEIN AEJ, Mackay TM, van der Geest LGM, van Eijck CHJ, et al
    Effect of centralization and regionalization of pancreatic surgery on resection rates and survival.
    Br J Surg. 2021 Mar 19. pii: 6178575. doi: 10.1093.
    >> Share

  72. RICCI C, Partelli S, Landoni L, Rinzivillo M, et al
    Sporadic non-functioning pancreatic neuroendocrine tumours: multicentre analysis.
    Br J Surg. 2021 Mar 16. pii: 6173849. doi: 10.1093.
    >> Share

  73. VAN ROESSEL S, Janssen BV, Soer EC, Farina Sarasqueta A, et al
    Scoring of tumour response after neoadjuvant therapy in resected pancreatic cancer: systematic review.
    Br J Surg. 2021;108:119-127.
    >> Share

  74. BI F, Qian Y, Song L, Qu H, et al
    Genome sequencing of pancreatic cancer: differential expression by location.
    Br J Surg. 2021;108:e67-e68.
    >> Share

  75. OBA A, Inoue Y, Ono Y, Ishizuka N, et al
    Staging laparoscopy for pancreatic cancer using intraoperative ultrasonography and fluorescence imaging: the SLING trial.
    Br J Surg. 2021;108:115-118.
    >> Share

  76. RAU KM, Chang CS, Pei SN, Hsieh MC, et al
    Comment on: Phase I/II study of adding intraperitoneal paclitaxel in patients with pancreatic cancer and peritoneal metastasis.
    Br J Surg. 2021 Mar 12. pii: 6168654. doi: 10.1093.
    >> Share

  77. YAMADA S, Fujii T, Satoi S
    Author's reply: Phase I/II study of adding intraperitoneal paclitaxel in patients with pancreatic cancer and peritoneal metastasis (Br J Surg 2020; 107: 1811-1817).
    Br J Surg. 2021 Mar 6. pii: 6161217. doi: 10.1093.
    >> Share

    February 2021
  78. PAUSCH TM, Mitzscherling C, Aubert O, Liu X, et al
    Applying an intraoperative predictive indicator for postoperative pancreatic fistula: randomized preclinical trial.
    Br J Surg. 2021 Feb 20. pii: 6145318. doi: 10.1093.
    >> Share

  79. STEPHENS JR, Wong JLC, Broomhead R, Stumpfle R, et al
    Raised serum amylase in patients with COVID-19 may not be associated with pancreatitis.
    Br J Surg. 2021 Feb 4. pii: 6128540. doi: 10.1093.
    >> Share

    January 2021
  80. YAMADA S, Fujii T, Satoi S
    Author response to: Comment on: Phase I/II study of adding intraperitoneal paclitaxel in patients with pancreatic cancer and peritoneal metastasis.
    Br J Surg. 2021;108:e56.
    >> Share

  81. YADAV T, Kurdia K, Irrinki S
    Intraperitoneal paclitaxel for pancreatic cancer with peritoneal metastasis.
    Br J Surg. 2021;108:e55.
    >> Share

  82. YU X
    Comment on: Acute pancreatitis in a COVID-19 patient.
    Br J Surg. 2021;108:e48.
    >> Share

  83. HIPP J, Hussung S, Timme-Bronsert S, Boerries M, et al
    Perioperative cell-free mutant KRAS dynamics in patients with pancreatic cancer.
    Br J Surg. 2021 Jan 26. pii: 6120257. doi: 10.1093.
    >> Share

  84. WENNERBLOM J, Ateeb Z, Jonsson C, Bjornsson B, et al
    Reinforced versus standard stapler transection on postoperative pancreatic fistula in distal pancreatectomy: multicentre randomized clinical trial.
    Br J Surg. 2021 Jan 20. pii: 6104783. doi: 10.1093.
    >> Share

    October 2020
  85. BALZANO G, Falconi M
    Author response to: Modelling centralization of pancreatic surgery: some additional considerations.
    Br J Surg. 2020 Oct 13. doi: 10.1002/bjs.12056.
    >> Share

  86. GIANOTTI L
    Modelling centralization of pancreatic surgery: some additional considerations.
    Br J Surg. 2020 Oct 13. doi: 10.1002/bjs.12057.
    >> Share

  87. BHORIWAL S, Kumar S, Mishra A, Kumar N, et al
    Comment on: Randomized clinical trial of pancreaticogastrostomy versus pancreaticojejunostomy on the rate and severity of pancreatic fistula after pancreaticoduodenectomy.
    Br J Surg. 2020 Oct 10. doi: 10.1002/bjs.12045.
    >> Share

  88. SALVIA R, Marchegiani G
    Evolving management of pancreatic cystic neoplasms.
    Br J Surg. 2020;107:1393-1395.
    >> Share

    September 2020
  89. WENIGER M, Hank T, Qadan M, Ciprani D, et al
    Influence of Klebsiella pneumoniae and quinolone treatment on prognosis in patients with pancreatic cancer.
    Br J Surg. 2020 Sep 30. doi: 10.1002/bjs.12003.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016